Board Member
Spruce Biosciences, Inc. (SPRB)Equibles does not estimate personal net worth.
Get an email with a short summary when Spruce Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get SPRB alertsJavier Szwarcberg is recorded as Board Member and CEO at Spruce Biosciences, Inc. (SPRB). The newest filing on record that lists Javier Szwarcberg as Board Member and CEO at Spruce Biosciences, Inc. (SPRB) is dated April 9, 2026. The proxy statement of Spruce Biosciences, Inc. reports total compensation of $2,910,573 for Javier Szwarcberg in fiscal 2025, including a base salary of $610,000. Disclosed compensation is on record for 5 fiscal years. Javier Szwarcberg has spoken on 4 investor events across 1 company, most recently for Spruce Biosciences, Inc. on October 22, 2026. Spruce Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Spruce Biosciences, Inc. includes Michael Grey (Chairman), Samir Gharib (CFO), Keli Walbert (Board Member) and 2 others.
“And thanks so much for hosting us at the conference. It's been a busy day with a lot of meetings, so I appreciate the fireside chat as well. MPS3V is a neuronopathic mucopolysaccharidosis.”
“So it's a great pleasure to be speaking with you today and telling you a bit about Spruce Biosciences. I'll be making some statements along the way. I'll refer you to our SEC filings for further reference.”
“So it's a great pleasure to be speaking with you today and telling you a bit about Spruce Biosciences. I'll be making some statements along the way. I'll refer you to our SEC filings for further reference.”
“So, we're in the process of making the first PPQ batch. We've already completed and executed two of the DS batches that will go into the PPQ. We will put four DS batches into the first, second, and third PPQ batches, DP batches, which will be submitted to the FDA.”
Start not stated–present
Last confirmed April 9, 2026
Start not stated–present
Last confirmed April 9, 2026
Biotechnology · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Spruce Biosciences, Inc. (SPRB) | M.D., MPH Chief Executive Officer | $610,000 | $2,910,573 |
| 2024 | Spruce Biosciences, Inc. (SPRB) | M.D., MPH Chief Executive Officer | $610,000 | $1,532,187 |
| 2023 | Spruce Biosciences, Inc. (SPRB) | M.D., MPH Chief Executive Officer | $580,000 | $2,157,418 |
| 2022 | Spruce Biosciences, Inc. (SPRB) | M.D., MPH Chief Executive Officer | $540,000 | $4,490,855 |
| 2021 | Spruce Biosciences, Inc. (SPRB) | M.D., MPH Chief Executive Officer | — | — |
